Vol 1, No 3 (2010)

Date published: 2010-07-27

Table of Contents

open access


Myelodysplastic/myeloproliferative neoplasms - recent advances and diagnostic issues

Monika Prochorec-Sobieszek

Review paper

Hematologia 2010;1(3):185-194.

Pathogenesis of chronic myeloid leukemia - from gene to targeted therapy

Joanna Żołnierowicz, Jerzy Kawiak, Grażyna Hoser

Review paper

Hematologia 2010;1(3):195-218.

Diagnosis and monitoring of chronic myeloid leukemia therapy

Tomasz Sacha, Kajetana Foryciarz

Review paper

Hematologia 2010;1(3):219-228.

The use of tyrosine kinase inhibitors in the second line treatment of patients with chronic myeloid leukemia

Aleksander B. Skotnicki, Tomasz Sacha, Kajetana Foryciarz

Review paper

Hematologia 2010;1(3):229-238.

Compliance during therapy of patients with chronic myeloid leukemia

Witold Prejzner

Review paper

Hematologia 2010;1(3):239-243.

Updated concepts in the treatment of chronic myeloid leukemia in 2010

Andrzej Hellmann

Review paper

Hematologia 2010;1(3):244-248.

Tyrosine kinase inhibitors-induced myelosuppression - case report

Małgorzata Całbecka

Case report

Hematologia 2010;1(3):249-253.

Imatinib-induced toxic liver failure in patients with chronic myeloid leukemia

Agnieszka Kołkowska-Leśniak, Katarzyna Budziszewska, Ilona Seferyńska, Krzysztof Warzocha

Case report

Hematologia 2010;1(3):254-260.


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.